• Explore /
  • Poster
  • / Phase 2, randomized, double-blind trial of EC-18 versus placebo to mitigate the development and time course of oral mucositis from concomitant chemoradiation for head and neck cancer.

Phase 2, randomized, double-blind trial of EC-18 versus placebo to mitigate the development and time course of oral mucositis from concomitant chemoradiation for head and neck cancer.

Abstract Poster

Authors

null

Christina Henson

University of Oklahoma Health Sciences Center, Oklahoma City, OK

Christina Henson , Daniel Clayburgh , Arielle Shebay Lee , Deborah J.L. Wong , Mahesh R. Kudrimoti , Douglas Adkins , Steve P. Lee , Noah Kalman , Peter John Oppelt , Krishna A. Rao , Ji Sun Park , Sookyung Oh , Koeun Kim , Sun Young Yoon , Ki Young Sohn , Stephen T. Sonis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Palliative Care and Symptom Management

Clinical Trial Registration Number

NCT03200340

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 12106)

DOI

10.1200/JCO.2022.40.16_suppl.12106

Abstract #

12106

Poster Bd #

351

Abstract Disclosures

Similar Posters

First Author: Marcelo Raul Bonomi

First Author: Jon Holmlund

First Author: Andrew Peter Dean

First Author: William D. Tap